TH MEDICAL-B (02697): Joint Company Secretary Lin Huiyi Passes Away
TH MEDICAL-B (02697) announced that Ms. Lin Huiyi, the Company's joint company secretary, the Company's authorized representative appointed under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the authorized person authorized to accept service of legal process and notices on behalf of the Company in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) and Rule 19A.13(2) of the Listing Rules, passed away on October 28, 2026.
TH MEDICAL-B (02697) announced that Ms. Lin Huiyi, the Company's joint company secretary, the Company's authorized representative appointed under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the authorized person authorized to accept service of legal process and notices on behalf of the Company in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) and Rule 19A.13(2) of the Listing Rules, passed away on October 28, 2026.
Related Articles
Shengda Resources (000603.SZ) plans to acquire no less than 58% equity interest in Fangxin Mining through equity transfer and capital increase.
Traffic Control Technology (688015.SH) independent director proposes share repurchase of RMB50 million to RMB100 million.
SEVEN ELEMENTS (01660): Wu Jiajun Appointed as Independent Non-Executive Director
Shengda Resources (000603.SZ) plans to acquire no less than 58% equity interest in Fangxin Mining through equity transfer and capital increase.
Traffic Control Technology (688015.SH) independent director proposes share repurchase of RMB50 million to RMB100 million.
SEVEN ELEMENTS (01660): Wu Jiajun Appointed as Independent Non-Executive Director
